-The Times of India NEW DELHI: In an attempt to empower consumers and save them from paying more for medicines, the government is set to make it mandatory for chemists to mention in the bill whether they are selling a price-controlled product or not. Besides, the bill will also mention the price of the medicine as capped by the government. The move will enable a consumer to make an informed choice while...
More »SEARCH RESULT
Total Matching Records found : 501
Appeasement for none
-Business Standard Intellectual property policy should focus on implementation A preliminary draft of a new intellectual property rights policy for India has been the occasion for much discussion. Commerce Minister Nirmala Sitharaman even felt it necessary to assert on Twitter that the proposed revamp is not meant to appease the United States, given that this remains a major outstanding irritant in relations between the two countries. The government has argued that the...
More »Medicines in India, for India -Pavan Srinath
-The Hindu Tropical diseases have often been neglected by pharmaceuticals because the size of the drug market is smaller, people have lower incomes and companies are uncertain about IPR January marked an important breakthrough in the fight against tropical diseases. Researchers and the International Centre for Genetic Engineering and Biotechnology (ICGEB) in Delhi found a drug candidate that prevented TB and malaria pathogens from infecting human blood cells. It is not just that...
More »These rancid rankings -Shamnad Basheer
-The Indian Express "If we did not have a patent system, it would be irresponsible, on the basis of our present knowledge of its economic consequences, to recommend instituting one." So said Fritz Machlup, a wise American economist several decades ago. His words remain as true now as they were then. For, the patent system is one of the most faulty legal regimes that one could possibly have conceived. It purports...
More »Indian drug cos worried about patent regime changes -PT Jyothi Datta
-The Hindu Business Line Seek clarification on US trade representative's testimony that India has committed to address IP issues that concern America Mumbai: Has India informally agreed to make changes in its Intellectual Property Rights regime on the basis of US concerns? A sizeable section of the Indian Pharmaceutical industry and some pro-health groups are worried that it has, following US Trade Representative Ambassador Michael Froman's testimony to the Senate Committee on...
More »
